Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Competitive Fitness of Essential Gene Knockdowns Reveals a Broad-Spectrum Antibacterial Inhibitor of the Cell Division Protein FtsZ.

Hogan AM, Scoffone VC, Makarov V, Gislason AS, Tesfu H, Stietz MS, Brassinga AKC, Domaratzki M, Li X, Azzalin A, Biggiogera M, Riabova O, Monakhova N, Chiarelli LR, Riccardi G, Buroni S, Cardona ST.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e01231-18. doi: 10.1128/AAC.01231-18. Print 2018 Dec.

2.

Investigating the Mechanism of Action of Diketopiperazines Inhibitors of the Burkholderia cenocepacia Quorum Sensing Synthase CepI: A Site-Directed Mutagenesis Study.

Buroni S, Scoffone VC, Fumagalli M, Makarov V, Cagnone M, Trespidi G, Rossi E, Forneris F, Riccardi G, Chiarelli LR.

Front Pharmacol. 2018 Jul 31;9:836. doi: 10.3389/fphar.2018.00836. eCollection 2018.

3.

Antimicrobial activity of six essential oils against Burkholderia cepacia complex: insights into mechanism(s) of action.

Perrin E, Maggini V, Maida I, Gallo E, Lombardo K, Madarena MP, Buroni S, Scoffone VC, Firenzuoli F, Mengoni A, Fani R.

Future Microbiol. 2018 Jan;13:59-67. doi: 10.2217/fmb-2017-0121. Epub 2017 Dec 4.

PMID:
29199856
4.

Subfunctionalization influences the expansion of bacterial multidrug antibiotic resistance.

Perrin E, Fondi M, Bosi E, Mengoni A, Buroni S, Scoffone VC, Valvano M, Fani R.

BMC Genomics. 2017 Oct 30;18(1):834. doi: 10.1186/s12864-017-4222-4.

5.

Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches.

Scoffone VC, Chiarelli LR, Trespidi G, Mentasti M, Riccardi G, Buroni S.

Front Microbiol. 2017 Aug 22;8:1592. doi: 10.3389/fmicb.2017.01592. eCollection 2017. Review.

6.

Biochemical Characterization of Glutamate Racemase-A New Candidate Drug Target against Burkholderia cenocepacia Infections.

Israyilova A, Buroni S, Forneris F, Scoffone VC, Shixaliyev NQ, Riccardi G, Chiarelli LR.

PLoS One. 2016 Nov 29;11(11):e0167350. doi: 10.1371/journal.pone.0167350. eCollection 2016.

7.

Discovery of new diketopiperazines inhibiting Burkholderia cenocepacia quorum sensing in vitro and in vivo.

Scoffone VC, Chiarelli LR, Makarov V, Brackman G, Israyilova A, Azzalin A, Forneris F, Riabova O, Savina S, Coenye T, Riccardi G, Buroni S.

Sci Rep. 2016 Sep 1;6:32487. doi: 10.1038/srep32487.

8.

The Crystal Structure of Burkholderia cenocepacia DfsA Provides Insights into Substrate Recognition and Quorum Sensing Fatty Acid Biosynthesis.

Spadaro F, Scoffone VC, Chiarelli LR, Fumagalli M, Buroni S, Riccardi G, Forneris F.

Biochemistry. 2016 Jun 14;55(23):3241-50. doi: 10.1021/acs.biochem.6b00178. Epub 2016 Jun 2.

PMID:
27198181
9.

Efflux-mediated resistance to a benzothiadiazol derivative effective against Burkholderia cenocepacia.

Scoffone VC, Ryabova O, Makarov V, Iadarola P, Fumagalli M, Fondi M, Fani R, De Rossi E, Riccardi G, Buroni S.

Front Microbiol. 2015 Aug 5;6:815. doi: 10.3389/fmicb.2015.00815. eCollection 2015.

10.

Differential roles of RND efflux pumps in antimicrobial drug resistance of sessile and planktonic Burkholderia cenocepacia cells.

Buroni S, Matthijs N, Spadaro F, Van Acker H, Scoffone VC, Pasca MR, Riccardi G, Coenye T.

Antimicrob Agents Chemother. 2014 Dec;58(12):7424-9. doi: 10.1128/AAC.03800-14. Epub 2014 Sep 29.

11.

Mechanism of resistance to an antitubercular 2-thiopyridine derivative that is also active against Burkholderia cenocepacia.

Scoffone VC, Spadaro F, Udine C, Makarov V, Fondi M, Fani R, De Rossi E, Riccardi G, Buroni S.

Antimicrob Agents Chemother. 2014;58(4):2415-7. doi: 10.1128/AAC.02438-13. Epub 2014 Jan 6.

Supplemental Content

Loading ...
Support Center